臺灣博碩士論文加值系統

小腦脊髓萎縮運動失調症是一種神經性疾病，且有許多亞型已被找出。而其中第三型小腦脊髓萎縮運動失調症是最常見的一種。這個疾病是由於CAG三個核苷酸重複片段擴張而造成，而這些CAG三個核苷酸重複片段最後會被轉譯成多麩胺酸。而致病蛋白已被確認為突變的ataxin-3。之前的研究結果證實，不正常的ataxin-3蛋白會造成某些基因的表現改變，蛋白質間不正常的作用和蛋白質不正常摺疊，最後導致神經細胞的死亡。Bcl-2是控制細胞死亡的蛋白家族中典型的一種。已經知道過量表達Bcl-2可以保護神經細胞去對抗多種疾病的傷害。我們建立了有GFP標記且帶有全長MJD基因的細胞株COS7-MJD26-GFP和COS7-MJD78-GFP。西方墨點法的結果指出在與COS7-MJD26-GFP相較下，含突變ataxin-3細胞的Bcl-2蛋白表現量下降。同樣地，半定量RT-PCR的結果也顯示在COS7-MJD78-GFP細胞內bcl-2 mRNA 同樣呈現下降的現象。觀察到這樣的結果可以表示，Bcl-2蛋白的下降可能是因為在mRNA程度上的缺失。然而Bcl-2啟動子在COS7-MJD78-GFP細胞內的活性都遠高於COS7-MJD26- GFP細胞，這個結果顯示Bcl-2蛋白表達量的下降可能是因為mRNA穩定度上的缺失。因此，我們使用腺嘌呤類似物DRB去抑制mRNA的合成，並再利用半定量RT-PCR去估計bcl-2 mRNA的降解速率。我們的結果指出，在COS7-MJD78-GFP細胞內bcl-2 mRNA 的降解速度，約是在COS7-MJD26-GFP細胞中的五倍。在bcl-2 mRNA 3’端不轉錄區域內的AU-rich 序列對ARE結合蛋白是一段很重要的區域，ARE結合蛋白可以經由正向或是負向的方式去調節mRNA穩定度。首先我們研究nucleolin這個ARE結合蛋白在MJD細胞模型內的作用，然而從西方點墨法的結果顯示，nucleolin的表達在細胞 表達MJD78-GFP或MJD26-GFP的質體，並沒有顯著差異。目前我們仍在進一步的分析，其他的ARE結合蛋白，是否會被突變的ataxin-3所影響。

Spinocerebellar ataxias are neurological disorders, and many subtypes were identified. Machado-Joseph disease (MJD) / SCA3 is the most common type. This disease is caused by CAG trinucleotide repeat expansion and the abnormal CAG repeats are transcribed and translated into polyglutamine. The pathogenic protein is defined as mutant ataxin-3. Previous studies demonstrated that mutant ataxin-3 causes altered gene expression, abnormal protein interaction and protein unfolding, eventually leading to neuronal cell death. Bcl-2 (B-cell lymphoma) is the prototype of a growing family of proteins which control cell death. It is known that overexpression of Bcl-2 protects neurons from a variety of pathological insults. COS7-MJD26-GFP and COS7-MJD78-GFP, which were stably transfected with full length MJD gene with GFP-tagged, were established in our laboratory. Western blot analysis revealed that Bcl-2 protein expression is decreased in cells containing mutant ataxin-3, when compared with that of COS7-MJD26- GFP cells. Consistently, results from semi-quantitative RT-PCR demonstrated that Bcl-2 mRNA expression is decreased in COS7- MJD78-GFP cells. This observation suggested that the down-regulation of Bcl-2 protein may be due to defects in mRNA level. However, the promoter activity in COS7-MJD78-GFP cells was much higher than that of COS7-MJD26-GFP, suggesting that the decrease of Bcl-2 expression may be due to defects in mRNA stability. Therefore, 5,6-Dichloro -benzimidazole 1-β-D-ribofuranoside (DRB), an adenosine analogue to inhibit mRNA synthesis, was used to estimate Bcl-2 mRNA degradation rate by semi-quantitative RT-PCR. Our results indicated that the bcl-2 mRNA decay in COS7-MJD78-GFP cells is about five-fold faster than that in COS7-MJD26-GFP. It is known that AU-rich elements (AREs) in 3’UTR of Bcl-2 mRNA are important regions for ARE binding proteins, which modulate the stability of ARE-containing mRNA in both positive and negative fashions. Effect of Nucleolin, an AU-rich element binding protein, was first investigated in our MJD cellular model. However, Western blot analysis revealed that nucleolin expression showed no difference between cells expressing with MJD78-GFP and MJD26-GFP. Further analysis to study which ARE binding protein affected by mutant ataxin-3 is under way.

目錄

中文摘要……………………………………………………………….2-3
英文摘要……………………………………………………………….4-5
前言…………………………………………………………………...6-13
材料及方法……………………………………………………….…14-19
結果……………………………………………………………….…20-27
討論……………………………………………………………….…28-35
參考文獻…………………………………………………………….36-41
圖表………………………………………………………………….42-52
附錄………………………………………………………………….53-56

Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R., and Finkbeiner, S. (2004). Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 431, 805-810.

Bandyopadhyay, S., Sengupta, T.K., Fernandes, D.J., and Spicer, E.K. (2003). Taxol- and okadaic acid-induced destabilization of bcl-2 mRNA is associated with decreased binding of proteins to a bcl-2 instability element. Biochem Pharmacol. 66, 1151-1162.

Barreau, C., Paillard, L., and Osborne, H.B. (2006). AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33, 7138-7150.

Bates, G.P., Mangiarini, L., Mahal, A., and Davies, S.W. (1997). Transgenic models of Huntington's disease. Hum Mol Genet. 10, 1633-1637.

Berke, S.J., Chai, Y., Marrs, G.L., Wen, H., and Paulson, H.L. (2005). Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem. 280, 32026-32034.

Bevilacqua, A., Ceriani, M.C., Canti, G., Asnaghi, L., Gherzi, R., Brewer, G., Papucci, L., Schiavone, N., Capaccioli, S., and Nicolin, A. (2003). Bcl-2 protein is required for the adenine/uridine-rich element (ARE)-dependent degradation of its own messenger. J Biol Chem. 26, 23451-23459.

Burnett, B.G., and Pittman, R.N. (2005). The polyglutamine neuro- degenerative protein ataxin 3 regulates aggresome formation. Proc Natl Acad Sci U S A. 102, 4330-4335.

Burright, E.N., Orr, H.T., and Clark, H.B. (1997). Mouse models of human CAG repeat disorders. Brain Pathol. 3, 965-977.

Chai, Y., Berke, S.S., Cohen, R.E., and Paulson, H.L. (2004). Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem. 279, 3605-3611.

Coutinho, P., Calheiros, J.M. and Andrade, C. (1977). On a new degenerative disorder of the central nervous system, inherited in an autosomal dominant mode and affecting people of Azorean extraction. O Medico. 82, 446-448.

Doss-Pepe, E.W., Stenroos, E.S., Johnson, W.G., and Madura, K. (2003). Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol Cell Biol. 23, 6469-6483.

Everett, C.M., and Wood, N.W. (2004). Trinucleotide repeats and neuro- degenerative disease. Brain. 127, 2385-2405.

Ghobrial, I.M., Witzig, T.E., and Adjei, A.A. (2006). Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 55, 178-194.

Goti, D., Katzen, S.M., Mez, J., Kurtis, N., Kiluk, J., Ben-Haiem, L., Jenkins, N.A., Copeland, N.G., Kakizuka, A., Sharp, A.H., Ross, C.A., Mouton, P.R., and Colomer, V. (2005). A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci. 45, 10266-10279.

Jiang, H., Nucifora ja, F.C., Ross, C.A., and Defranco, D.B. (2003). Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum. Mol. Genet. 12, 1-12.

Lang, G., Gombert, W.M., and Gould, H.J. (2005). A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene. Immunology 114, 25-36.

Lapucci, A., Donnini, M., Papucci, L., Witort, E., Tempestini, A., Bevilacqua, A., Nicolin, A., Brewer, G., Schiavone, N., and Capaccioli, S. (2002). AUF1 is a bcl-2 A + U-rich element-binding protein involved in bcl-2 mRNA destabilization during apoptosis. J Biol Chem. 277, 16139-16146.

Leavitt, B.R., Wellington, C.L., and Hayden, M.R. (1999). Recent insights into the molecular pathogenesis of Huntington disease. Semin Neurol. 19, 385-395.

Li, F., Macfarian, T., Pittman, R.N., and Chakravarti, D. (2002). Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J. Biol. Chem. 277, 45004-45012.

Liu, Y.Z., Boxer, L.M., and Latchman, D.S. (1999). Activation of the bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic Acids Res. 27, 2086-90.

Manto, M.U. (2005). The wide spectrum of spinocerebellar ataxis (SCAs). Cerebellum. 4, 2-6.

Morfini, G,. Pigino, G., and Brady, S.T. (2005). Polyglutamine expansion diseases: failing to deliver. Trends Mol Med. 11, 64-70.

Preisinger, E., Jordan, B.M., Kazantsev, A., and Housman, D. (1999). Evidence for a recruitment and sequestration mechanism in Huntington's disease. Philos Trans R Soc Lond B Biol Sci. 354, 1029-1034.

Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K.A., Boxer, L.M., Heasley, L.E., and Reusch, J.E. (2000). Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem. 20, 1324-1327.

Sadoul, R. (1998). Bcl-2 family members in the development and degenerative pathologies of the nervous system. Cell Death Differ. 5, 805-815.

Schöls, L., Bauer, P., Schmidt, T., Schulte, T., and Riess, O. (2004). Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 3, 291-304.

Sengupta, T.K., Bandyopadhyay, S., Fernandes, D.J., and Spicer, E.K. (2004). Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J Biol Chem. 12, 10855-10863.

Smith, M.D., Ensor, E.A., Coffin, R.S., Boxer, L.M., and Latchman, D.S. (1998). Bcl-2 transcription from the proximal p2 promoter is activated in neuronal cells by Brn-3a POU family transcription factor. J. Biol. Chem. 273, 16715-16722.

Takiyama, J., Tanaka, J., Arai, K., Funata, N., Hattori, T., Funkada, T., Fujigaski, H., and Uchihara, T. (1993). The gene for Machado-Joseph diseases is mapped to chromosome 14q. Nature Genet. 4, 300-304.

Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N.R., Doi, H., Kurosawa, M., Nekooki, M., and Nukina, N. (2004). Trehalose alleviates polyglutamine- mediated pathology in a mouse model of Huntington disease. Nat Med. 10, 148-154.

Tsai, H.F., Liu, C. S., Liu, T.M., Wen, F.C., Lin, S.J., Liu, C.C. Yang, D.K., Li, C., and Hsieh, M. (2004a) Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol. Scand. 5, 355-60.

Tsai, H.F., Tsai, H.J., and Hsieh, M. (2004b). Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells. Biochem. Biophys. Res. Commun. 324, 1274-1282.

Tsuji, S. (1997). Molecular genetics of triplet repeats: unstable expansion of triplet repeats as a new mechanism for neurodegenerative diseases. Intern Med. 36, 3-8.

Wilson, B.E., Mochon, E., and Boxer, L.M. (1996). Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol. 10, 5546-5556.